Pearl Pathways Getting National Exposure

Pearl Pathways continues to see an increase in its national exposure. PharmaVOICE has featured Pearl Pathways twice in the last year. In the January PharmaVOICE article titled “Commercialization to Repertoire”, Pearl Pathways president and CEO, Diana Caldwell, explained Pearl’s expansion of the breadth of services it can offer to its cusomtomers. In April, Chief Operating Officer, Gretchen Bowker, gave her views on the current state of IRBs in the PharmaVOICE article titled “Remaking the RULES”. To read Diana’s comments about Pearl’s expansion, click here. To see the article featuring Gretchen’s views about IRBs, click here.

Obstacles Facing Biosimilars

Still in its infancy in the U.S., the industry faces some growing pains.

Life Science Accelerated

Pearl Pathways is a comprehensive life science product development services company. Every day we strive to provide our customers top quality service, unyielding ethics, and efficient services through our team of experts. Pearl Pathways supports biopharmaceutical, medical device, and diagnostic companies as well as life science service providers with clinical, regulatory, and quality compliance needs. Our full-service central IRB supports all aspects of human research.